The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

December 1, 2008 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Even when it is not active, SLE may cause problems later, such as kidney disease, which can progress to renal failure and can require dialysis. This can be prevented by early and aggressive treatment at the first signs of kidney disease. Another problem is accelerated atherosclerosis, which increases the risk of heart attacks and other cardiovascular events. It is crucial that SLE patients reduce other risk factors such as smoking, high blood pressure, and high cholesterol to reduce their risk for these complications. Most people with SLE can live normal lives, but this disorder must be carefully monitored and treatment should be adjusted as necessary to prevent serious complications.

You Might Also Like
  • Anti-Mitochondrial Antibodies & Systemic Lupus Erythematosus
  • Tabalumab Modestly Effective in Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report
Explore This Issue
December 2008
Also By This Author
  • Coding Corner Question: Coding Scenario for 1997 Musculoskeletal Exam

Download the complete SLE fact sheet and other patient-education materials at www.rheumatology.org by following the links to patient education from the Practice Support Menu.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College, SLE (Lupus) Tagged With: Diagnostic Criteria, Lupus, Patient Fact Sheet, SLE, systemic lupus erythematousIssue: December 2008

You Might Also Like:
  • Anti-Mitochondrial Antibodies & Systemic Lupus Erythematosus
  • Tabalumab Modestly Effective in Systemic Lupus Erythematosus
  • Systemic Lupus Erythematosus Without Kidney Involvement: A Case Report
  • Accelerating Medicines Partnership Targets Therapies for Rheumatoid Arthritis, Systemic Lupus Erythematosus

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.